Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 759 for “"Cancer immunotherapy"”.

  1. TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY

    Immunotherapies have shown remarkable success in cancer treatment. However, diverse tumor-specific immunosuppressive mechanisms dampen response rates highlighting the need for novel immunotherapeutic targets. Protein Tyrosine Phosphatase Non-Receptor Type 22 (PTPN22) is a phosphatase specific to …

    jhu Repository record for TARGETING PTPN22 FOR CANCER IMMUNOTHERAPY (opens in a new tab) Embargoed until 2027-05-01

  2. NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY

    … to provide synergistic efficacy against primary cancers in animals with just the use of a single wavelength laser at low doses. However, given the limited efficacy of phototherapy towards deep tissue tumours, there is a need to develop combinatorial strategies that goes beyond the treatment of …

    nus Repository record for NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY (opens in a new tab) Download file for NANOPARTICLE APPROACH TO CANCER IMMUNOTHERAPY (opens in a new tab)

  3. IMPROVING OUTCOMES FOR CANCER IMMUNOTHERAPY

    Cancer immunotherapy has demonstrated immense promise in the past decade. Immune checkpoint therapy has shown unprecedented responses in many cancers; however most patients fail to respond to checkpoint therapy. This highlights the need to develop a better understanding of factors in the tumor …

    mcmaster Repository record for IMPROVING OUTCOMES FOR CANCER IMMUNOTHERAPY (opens in a new tab)

  4. Systems biology models for cancer immunotherapy

    Cancer is a complex disease that continues to affect millions of people around the world every year. With ever-improving science and technology, several forms of treatment have been introduced within the past century and continue to be developed so as to provide increasing chances of survival and …

    waterloo Repository record for Systems biology models for cancer immunotherapy (opens in a new tab)

  5. Cancer Immunotherapy: Limitations and Potential Strategies

    Cancer immunotherapy is a treatment strategy which uses a patient's own immune system to induce or enhance immune responses against cancer. Although immunotherapy has been used for the treatment of a variety of cancers since the early 1900s, it represents the youngest pillar of cancer treatments …

    unr Repository record for Cancer Immunotherapy: Limitations and Potential Strategies (opens in a new tab)

  6. Gold Nanovaccine Strategies for Cancer Immunotherapy

    Gold nanoparticles have excellent properties for cancer therapeutics because their tunable size and surface chemistry make them customizable for many applications. For immunotherapy applications in particular, we can leverage their natural biodistribution to the spleen and immune cells for …

    rice Repository record for Gold Nanovaccine Strategies for Cancer Immunotherapy (opens in a new tab)

  7. OBESITY AND SEX IN CANCER IMMUNOTHERAPY

    … condition often associated with poor outcomes in cancer, yet clinical evidence suggests that obese patients may benefit disproportionately from immunotherapy respect to the lean population. The mechanisms underlying this phenomenon, particularly in relation to sex, remain unclear. In this thesis, …

    milano Repository record for OBESITY AND SEX IN CANCER IMMUNOTHERAPY (opens in a new tab)

  8. Dendritic Cell Reprogramming for Cancer Immunotherapy

    The success of cancer immunotherapy depends on the priming of tumor-specific T and B lymphocytes. However, tumor cells often downregulate antigen presentation and mount an immunosuppressive tumor microenvironment (TME), which excludes immunogenic cells and hinders broad success of cancer …

    lund Repository record for Dendritic Cell Reprogramming for Cancer Immunotherapy (opens in a new tab) Download PDF for Dendritic Cell Reprogramming for Cancer Immunotherapy (opens in a new tab)

  9. Janus particles designed for cancer immunotherapy

    … CD8+ T cells commonly migrate to solid tumors, cancer cells suppress and evade these cells through a variety of intrinsic and extrinsic mechanisms. As a result, recruited cytotoxic T cells are rendered anergic or apoptotic and are thus ineffective at killing cancer cells. Cancer is traditionally …

    gatech Repository record for Janus particles designed for cancer immunotherapy (opens in a new tab)

  10. Mathematical modeling of prostate cancer immunotherapy

    Immunotherapy, by enhancing the endogenous anti-tumor immune responses, is showing promising results for the treatment of numerous cancers refractory to conventional therapies. However, its effectiveness for advanced castration-resistant prostate cancer remains unsatisfactory and new therapeutic …

    trento Repository record for Mathematical modeling of prostate cancer immunotherapy (opens in a new tab)

  11. A PEPTIDE HYDROGEL VACCINE FOR CANCER IMMUNOTHERAPY

    Immunotherapy, especially immune checkpoint inhibitors, has revolutionized the treatment of cancer. Despite recent progress in cancer biology and drug discovery, immunotherapy benefits only a minority of patients. Resistance, whether primary or acquired, continues to limit the full potential of …

    jhu Repository record for A PEPTIDE HYDROGEL VACCINE FOR CANCER IMMUNOTHERAPY (opens in a new tab)

  12. Radiographic Challenges and Considerations with Cancer Immunotherapy

    … of immune checkpoint inhibitors in advanced lung cancer. MATERIALS AND METHODS: We performed a retrospective analysis of patients with advanced lung cancer treated with immune checkpoint inhibitor monotherapy. Demographic, disease, and treatment data were collected. Serial tumor dimensions were …

    utswmed Repository record for Radiographic Challenges and Considerations with Cancer Immunotherapy (opens in a new tab)

  13. ARTIFICIAL ANTIGEN PRESENTING CELLS FOR CANCER IMMUNOTHERAPY

    Artificial Antigen Presenting Cells (aAPC) are synthetic platforms for T cell activation, made by coupling T cell activating proteins to cell-sized, spherical particles. While this size and shape are chosen to mimic endogenous APC and simplify manufacture, respectively, platforms based on …

    jhu Repository record for ARTIFICIAL ANTIGEN PRESENTING CELLS FOR CANCER IMMUNOTHERAPY (opens in a new tab)

  14. IPSC-DERIVED IMMUNE CELLS FOR CANCER IMMUNOTHERAPY

    … cells (iPSCs) become attractive cell sources in cancer immunotherapy due to the properties of pluripotent differentiation potentials and unlimited proliferation. In this PhD thesis, we explored the potential of iPSC-derived immune cells for cancer immunotherapy. Starting from a healthy donor’s …

    nus Repository record for IPSC-DERIVED IMMUNE CELLS FOR CANCER IMMUNOTHERAPY (opens in a new tab) Download file for IPSC-DERIVED IMMUNE CELLS FOR CANCER IMMUNOTHERAPY (opens in a new tab)

  15. Phagocytic enhancement of macrophages for cancer immunotherapy

    The full abstract for this thesis is available in the body of the thesis, and will be available when the embargo expires.

    ubc Repository record for Phagocytic enhancement of macrophages for cancer immunotherapy (opens in a new tab) Download PDF for Phagocytic enhancement of macrophages for cancer immunotherapy (opens in a new tab)

  16. Engineering pH-responsive biomaterials for cancer immunotherapy

    Recent advances in immunotherapy have transformed cancer treatment, while highlighting the complex interactions between the immune system and tumors. For delivery of unstable molecules or immunogenic agents, these therapies often employ nanoformulations to deliver therapeutics to diseased tissue …

    washington Repository record for Engineering pH-responsive biomaterials for cancer immunotherapy (opens in a new tab)

Page 1 of 38